智通财经APP讯，百济神州(688235.SH)布2025年第一季度主要财务数据公告，报告期内，公司实现营业总收入80.48亿元，同比增长50.2%:其中产品收入79.85亿元，同比增长49.9%。营业利润、利润总额由亏损转为盈利。产品收入的增长主要得益于公司自研产品百悦泽®(泽布替尼胶囊),以及百泽安®(替雷利珠单抗)和安进授权产品的销售增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.